enGene Therapeutics Inc
enGene Therapeutics Inc (ENGN) Option Chain
As of September 18, 2026, enGene Therapeutics Inc is trading at $1.95, a +2.10% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 442.6%. IV Rank is —%.
Read more
Tracking the ENGN option chain helps you see every strike and expiry on enGene Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. enGene Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ENGN options activity at a glance. Use our scanner to monitor the ENGN option chain in real time and filter for the ENGN options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ENGN stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ENGN option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ENGN stock options are being actively traded and where they are not.
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls enGene Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ENGN options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ENGN stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile—
- Market cap (M$)128
- 52 weeks high-84.41%
- 52 weeks low36.43%
- Analyst recommendationHold
2.50 - Target price$3.43
75.90% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-09-08
- P/E—
- Future P/E—
- EPS (ttm)-2.08
- EPS growth next 5 years24.06%
As of September 18, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 52.64 | 14 | 0 | 2.95 | 0.95 | — | 3.90 | 1.00 | -47.64 | — | 0.05 | 0.00 | 0.05 | 0 | 0 | 47.36 |
| 73.89 | 137 | 0 | 0.15 | 0.00 | — | 0.15 | 2.00 | +4.71 | — | 0.35 | 0.05 | 0.30 | 0 | 59 | 26.11 |
| 83.53 | 70 | 0 | 0.40 | 0.00 | — | 0.40 | 3.00 | +57.07 | 0.55 | 1.70 | 1.05 | 0.07 | 0 | 0 | 16.47 |
As of September 18, 2026
Scan the full option chain in one place
Browse the full ENGN option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→